Interleukin-2 fusion protein with anti-CD3 single-chain Fv (sFv) selectively protects T cells from dexamethasone-induced apoptosis

Vaccine

Volumn 20, Issue 3-4, 2001, Pages 608-615

  Kim, Eui J ^a   Cho, Daeho ^b   Hwang, Seung Y ^c,d   Kim, Tae S ^a,d  

^a Chonnam National University   (South Korea)

^b Seoul National University   (South Korea)

^c Hanyang University   (South Korea)

^d GenoCheck Co Ltd   (South Korea)

Author keywords

Anti CD3; Apoptosis; Fusion vaccine; Interleukin 2; T cell

Indexed keywords

CD3 ANTIBODY INTERLEUKIN 2 FUSION PROTEIN; CD3 ANTIGEN; DEXAMETHASONE; DNA; HYBRID PROTEIN; INTERLEUKIN 2; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; PROTEIN BCL 2; RECOMBINANT PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; CELL POPULATION; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD3; APOPTOSIS; DEXAMETHASONE; FEMALE; GENES, BCL-2; IMMUNOGLOBULIN FRAGMENTS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES;

EID: 0035851376     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00331-0     Document Type: Article

References (37)

1. Physiological T-cell death: Susceptibility is modulated by activation, aging, and transformation, but the mechanism is constant
2. Cellular environments and apoptosis: Tissue microenvironments control activated T-cell death
3. Physiological cell death during development and its relationship to aging
4. Morphologic and biochemical hallmarks of apoptosis
5. Apoptotic DNA fragmentation
6. Apoptosis: An overview of the process and its relevance in disease
7. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis
8. Tumor cells induce apoptosis in lymphocytes
9. From apoptosis to autoimmunity: Insights from the signaling pathways leading to proliferation or to programmed cell death
10. Role of p53 in apoptosis
11. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
12. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
13. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
14. Interleukin-2
15. Interleukin-2 and the interleukin-2 receptor complex
16. IL-2 protects T lymphocytes from glucocorticoid-induced DNA fragmentation and cell death
17. IL-4 and IL-2 selectively rescue Th cell subsets from glucocorticoid-induced apoptosis
18. IL-2 rescues antigen-specific T cells from radiation or dexamethasone-induced apoptosis correlation with induction of Bcl-2
19. IL-2 and IL-7 but not IL-12 protect natural killer cells from death by apoptosis and up-regulate bcl-2 expression
20. An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production
21. Antigen-specific cytotoxicity and cell number of adoptively transferred T cells are efficiently maintained in vivo by re-stimulation with an antigen/interleukin-2 fusion protein
22. Injection with interleukin-4-secreting fibroblasts efficiently induces T helper type 2 cell-dominated immune response
23. Genetically engineered fibroblasts with antigen-presenting capability: Efficient induction of an antigen-specific cytotoxic T-lymphocyte response and protection against tumor development in vivo
24. Biological activity and in vivo clearance of antitumor antibody/cytokine fusion proteins
25. Idiotype-cytokine fusion proteins as cancer vaccines: Relative efficacy of IL-2, IL-4, and granulocyte macrophage colony-stimulating factor
26. + B cells and preserve expression of bcl-2
27. Bcl-2 overexpression is associated with resistance to dexamethasone, but not melphalan, in multiple myeloma cells
28. Role of NF-kappaB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2
29. In vitro treatment with retinoids decreases bcl-2 protein expression and enhances dexamethasone-induced cytotoxicity and apoptosis in multiple myeloma cells
30. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis
31. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation
32. Immunotherapy of cancer with genetically modified tumor vaccines
33. Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression
34. IL-6 rescues resting mouse T cells from apoptosis
35. Interleukin-10 rescues T cells from apoptotic cell death: Association with an upregulation of Bcl-2
36. Interferon-alpha protects myeloma cell lines from dexamethasone-induced apoptosis